c-Jun N-terminal kinase attenuates TNFα signaling by reducing Nox1-dependent endosomal ROS production in vascular smooth muscle cells

Free Radical Biology and Medicine

Volumn 86, Issue , 2015, Pages 219-227

  Choi, Hyehun ^a   Dikalova, Anna ^a   Stark, Ryan J ^a   Lamb, Fred S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

c Jun N terminal kinase; Endosome; NADPH oxidase 1; Superoxide; Tumor necrosis factor

Indexed keywords

ANISOMYCIN; DYNAMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE; TNFRSF1A PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; VASCULITIS; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; ENDOSOME; ENZYMOLOGY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; ENDOCYTOSIS; ENDOSOMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938507593     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.05.015     Document Type: Article

References (66)

1. A.H. Sprague, and R.A. Khalil Inflammatory cytokines in vascular dysfunction and vascular disease Biochem. Pharmacol. 78 2009 539 552
2. V.J. Dzau, R.C. Braun-Dullaeus, and D.G. Sedding Vascular proliferation and atherosclerosis: NEw perspectives and therapeutic strategies Nat. Med 8 2002 1249 1256
3. S. Feil, B. Fehrenbacher, R. Lukowski, F. Essmann, K. Schulze-Osthoff, M. Schaller, and R. Feil Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis Circ. Res. 115 2014 662 667
4. G. Genctoy, B. Altun, A. Alper Kiykim, M. Arici, Y. Erdem, M. Çaʇlar, Ü. Yasavul, Ç. Turgan, and Ş. Çaʇlar TNF alpha-308 genotype and renin-angiotensin system in hemodialysis patients: an effect on inflammatory cytokine levels? Artific. Organs 29 2005 174 178
5. K. Vaddi, F.A. Nicolini, P. Mehta, and J.L. Mehta Increased secretion of tumor necrosis factor-alpha and interferon-gamma by mononuclear leukocytes in patients with ischemic heart disease. Relevance in superoxide anion generation Circulation 90 1994 694 699
6. C. Tentolouris, D. Tousoulis, C. Antoniades, E. Bosinakou, M. Kotsopoulou, A. Trikas, P. Toutouzas, and C. Stefanadis Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy Int. J. Cardiol. 94 2004 301 305
7. A. Matsumori, T. Yamada, H. Suzuki, Y. Matoba, and S. Sasayama Increased circulating cytokines in patients with myocarditis and cardiomyopathy Br. Heart J. 72 1994 561 566
8. K. Peppel, L. Zhang, E.S. Orman, P.O. Hagen, A. Amalfitano, L. Brian, and N.J. Freedman Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms Cardiovasc. Res. 65 2005 674 682
9. S. Goetze, X.P. Xi, Y. Kawano, H. Kawano, E. Fleck, W.A. Hsueh, and R.E. Law TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent Hypertension 33 1999 183 189
10. H. Zhang, Y. Park, J. Wu, X. Chen, S. Lee, J. Yang, K.C. Dellsperger, and C. Zhang Role of TNF-alpha in vascular dysfunction Clin. Sci. (Lond.) 116 2009 219 230
11. H. Wajant, and P. Scheurich TNFR1-induced activation of the classical NF-kappaB pathway FEBS J. 278 2011 862 876
12. L. Cabal-Hierro, and P.S. Lazo Signal transduction by tumor necrosis factor receptors Cell Signal. 24 2012 1297 1305
13. D. Luo, Y. Luo, Y. He, H. Zhang, R. Zhang, X. Li, W.L. Dobrucki, A.J. Sinusas, W.C. Sessa, and W. Min Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis Am. J. Pathol. 169 2006 1886 1898
14. Y. Higuchi, C.F. McTiernan, C.B. Frye, B.S. McGowan, T.O. Chan, and A.M. Feldman Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy Circulation 109 2004 1892 1897
15. M. Rodriguez, L. Cabal-Hierro, M.T. Carcedo, J.M. Iglesias, N. Artime, B.G. Darnay, and P.S. Lazo NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2 J. Biol. Chem. 286 2011 22814 22824
16. S. Schutze, V. Tchikov, and W. Schneider-Brachert Regulation of TNFR1 and CD95 signalling by receptor compartmentalization Nat. Rev. Mol. Cell. Biol. 9 2008 655 662
17. W. Schneider-Brachert, V. Tchikov, J. Neumeyer, M. Jakob, S. Winoto-Morbach, J. Held-Feindt, M. Heinrich, O. Merkel, M. Ehrenschwender, D. Adam, R. Mentlein, D. Kabelitz, and S. Schutze Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles Immunity 21 2004 415 428
18. D. Loerke, M. Mettlen, D. Yarar, K. Jaqaman, H. Jaqaman, G. Danuser, and S.L. Schmid Cargo and dynamin regulate clathrin-coated pit maturation PLoS Biol. 7 2009 e1000057
19. J.R. Henley, E.W.A. Krueger, B.J. Oswald, and M.A. McNiven Dynamin-mediated Internalization of Caveolae J. Cell Biol. 141 1998 85 99
20. F.J. Miller, M. Filali, G.J. Huss, B. Stanic, A. Chamseddine, T.J. Barna, and F.S. Lamb Cytokine activation of nuclear factor κb in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3 Circ. Res. 101 2007 663 671
21. F.J. Miller Jr., X. Chu, B. Stanic, X. Tian, R.V. Sharma, R.L. Davisson, and F.S. Lamb A differential role for endocytosis in receptor-mediated activation of Nox1 Antioxid. Redox Signal. 12 2010 583 593
22. J.J. Matsuda, M.S. Filali, J.G. Moreland, F.J. Miller, and F.S. Lamb Activation of swelling-activated chloride current by tumor necrosis factor-α requires ClC-3-dependent endosomal reactive oxygen production J. Biol. Chem. 285 2010 22864 22873
23. B. Lassegue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol 285 2003 R277 R297
24. R.P. Brandes, and J. Kreuzer Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc. Res. 65 2005 16 27
25. M.Y. Lee, A. San Martin, P.K. Mehta, A.E. Dikalova, A.M. Garrido, S.R. Datla, E. Lyons, K.H. Krause, B. Banfi, J.D. Lambeth, B. Lassegue, and K.K. Griendling Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation Arterioscler. Thromb. Vasc. Biol. 29 2009 480 487
26. S. Xu, A.S. Shriver, D.K. Jagadeesha, A.H. Chamseddine, K. Szocs, N.L. Weintraub, K.K. Griendling, R.C. Bhalla, and F.J. Miller Jr. Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9 J. Vasc. Res. 49 2012 242 248
27. A. Dikalova, R. Clempus, B. Lassegue, G. Cheng, J. McCoy, S. Dikalov, A. San Martin, A. Lyle, D.S. Weber, D. Weiss, W.R. Taylor, H.H. Schmidt, G.K. Owens, J.D. Lambeth, and K.K. Griendling Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice Circulation 112 2005 2668 2676
28. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat. Rev. Immunol. 3 2003 745 756
29. H. Choi, H.N. Nguyen, and F.S. Lamb Inhibition of endocytosis exacerbates TNF-α-induced endothelial dysfunction via enhanced JNK and p38 activation Am. J. Physiol. Heart Circ. Physiol 306 2014 H1154 H1163
30. R. Metz, J. Patterson, and E. Wilson Vascular smooth muscle cells: isolation, culture, and characterization X. Peng, M. Antonyak, Cardiovascular development 2012 Humana Press 169 176
31. M.C. Zimmerman, M. Takapoo, D.K. Jagadeesha, B. Stanic, B. Banfi, R.C. Bhalla, and F.J. Miller Jr. Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells Hypertension 58 2011 446 453
32. E.A. Sprague, J.L. Kelley, C.A. Suenram, A.J. Valente, M. Abreu-Macomber, and C.J. Schwartz Stimulation of albumin endocytosis by cationized ferritin in cultured aortic smooth muscle cells Am. J. Pathol. 121 1985 433 443
33. J.D. Widder, W. Chen, L. Li, S. Dikalov, B. Thöny, K. Hatakeyama, and D.G. Harrison Regulation of tetrahydrobiopterin biosynthesis by shear stress Circ. Res. 101 2007 830 838
34. S.I. Dikalov, I.A. Kirilyuk, M. Voinov, and I.A. Grigor'ev EPR detection of cellular and mitochondrial superoxide using cyclic hydroxylamines Free Radic. Res. 45 2011 417 430
35. G.G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C.M. Matter, Z. Yang, T.F. Luscher, and F.C. Tanner Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents Circulation 114 2006 1512 1521
36. E. Macia, M. Ehrlich, R. Massol, E. Boucrot, C. Brunner, and T. Kirchhausen Dynasore, a cell-permeable inhibitor of dynamin Dev. Cell 10 2006 839 850
37. H. Damke, T. Baba, D.E. Warnock, and S.L. Schmid Induction of mutant dynamin specifically blocks endocytic coated vesicle formation J. Cell Biol. 127 1994 915 934
38. A. Sorkin, and M. von Zastrow Endocytosis and signalling: intertwining molecular networks Nat. Rev. Mol. Cell. Biol. 10 2009 609 622
39. G. Tang, Y. Minemoto, B. Dibling, N.H. Purcell, Z. Li, M. Karin, and A. Lin Inhibition of JNK activation through NF-kappaB target genes Nature 414 2001 313 317
40. E. De Smaele, F. Zazzeroni, S. Papa, D.U. Nguyen, R. Jin, J. Jones, R. Cong, and G. Franzoso Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling Nature 414 2001 308 313
41. A. Matsuzawa, and H. Ichijo Stress-responsive protein kinases in redox-regulated apoptosis signaling Antioxid. Redox Signal. 7 2005 472 481
42. P.R. Nelson, S. Yamamura, L. Mureebe, H. Itoh, and K.C. Kent Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase J. Vasc. Surg. 27 1998 117 125
43. D.N. Dhanasekaran, and E.P. Reddy JNK signaling in apoptosis Oncogene 27 2008 6245 6251
44. C. Tournier, P. Hess, D.D. Yang, J. Xu, T.K. Turner, A. Nimnual, D. Bar-Sagi, S.N. Jones, R.A. Flavell, and R.J. Davis Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 2000 870 874
45. J.M. Kyriakis, and J. Avruch Sounding the alarm: protein kinase cascades activated by stress and inflammation J. Biol. Chem. 271 1996 24313 24316
46. S. Gupta, T. Barrett, A.J. Whitmarsh, J. Cavanagh, H.K. Sluss, B. Derijard, and R.J. Davis Selective interaction of JNK protein kinase isoforms with transcription factors EMBO J. 15 1996 2760 2770
47. Z. Han, D.L. Boyle, L. Chang, B. Bennett, M. Karin, L. Yang, A.M. Manning, and G.S. Firestein c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis J. Clin. Invest. 108 2001 73 81
48. W. Wu, A. Muchir, J. Shan, G. Bonne, and H.J. Worman Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene Circulation 123 2011 53 61
49. M. Koller, S. Hayer, K. Redlich, R. Ricci, J.P. David, G. Steiner, J.S. Smolen, E.F. Wagner, and G. Schett JNK1 is not essential for TNF-mediated joint disease Arthritis Res. Ther. 7 2005 R166 R173
50. C. Tong, Z. Yin, Z. Song, A. Dockendorff, C. Huang, J. Mariadason, R.A. Flavell, R.J. Davis, L.H. Augenlicht, and W. Yang c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression Am. J. Pathol. 171 2007 297 303
51. Q.B. She, N. Chen, A.M. Bode, R.A. Flavell, and Z. Dong Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate Cancer Res. 62 2002 1343 1348
52. H.M. Shen, and Z.G. Liu JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species Free Radic. Biol. Med. 40 2006 928 939
53. Y. Gu, Y.C. Xu, R.F. Wu, R.F. Souza, F.E. Nwariaku, and L.S. Terada TNFalpha activates c-Jun amino terminal kinase through p47(phox) Exp. Cell Res. 272 2002 62 74
54. Y.C. Xu, R.F. Wu, Y. Gu, Y.S. Yang, M.C. Yang, F.E. Nwariaku, and L.S. Terada Involvement of TRAF4 in oxidative activation of c-Jun N-terminal kinase J. Biol. Chem. 277 2002 28051 28057
55. M. Saitoh, H. Nishitoh, M. Fujii, K. Takeda, K. Tobiume, Y. Sawada, M. Kawabata, K. Miyazono, and H. Ichijo Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 EMBO J. 17 1998 2596 2606
56. W. Min, Y. Lin, S. Tang, L. Yu, H. Zhang, T. Wan, T. Luhn, H. Fu, and H. Chen AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factor-induced ASK1-JNK activation Circ. Res. 102 2008 840 848
57. M. Yoshizumi, J. Abe, J. Haendeler, Q. Huang, and B.C. Berk Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species J. Biol. Chem. 275 2000 11706 11712
58. M.A. Bogoyevitch, and B. Kobe Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases Microbiol. Mol. Biol. Rev. 70 2006 1061 1095
59. Y.S. Kim, M.J. Morgan, S. Choksi, and Z.G. Liu TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death Mol. Cell 26 2007 675 687
60. J. Streeter, B.M. Schickling, S. Jiang, B. Stanic, W.H. Thiel, L. Gakhar, J.C. Houtman, and F.J. Miller Jr. Phosphorylation of Nox1 regulates association with NoxA1 activation domain Circ. Res. 115 2014 911 918
61. B.C. Berk Redox signals that regulate the vascular response to injury Thromb. Haemost. 82 1999 810 817
62. G.N. Rao, and B.C. Berk Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression Circ. Res. 70 1992 593 599
63. L.A. Pham-Huy, H. He, and C. Pham-Huy Free radicals, antioxidants in disease and health Int. J. Biomed. Sci. 4 2008 89 96
64. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354:447-455; 1999.
65. S. Yusuf, G. Dagenais, J. Pogue, J. Bosch, and P. Sleight Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N. Engl. J. Med. 342 2000 154 160
66. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:23-33; 2002.